Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Typology of Adherence in Adolescents: Phase II

ClinicalTrials.gov ID: NCT00106678

Public ClinicalTrials.gov record NCT00106678. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 3:13 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A number of factors influence HIV-positive adolescents' acceptance of and willingness to continue taking anti-HIV medicines. These factors include mental health and substance abuse issues, barriers such as lack of medical insurance, and cognitive-behavioral barriers (such as a person's impression of the impact of the medicines on his/her health and a person's sense of his/her ability to continue taking the medications prescribed). The purpose of this study is to use a survey to determine how common specific barriers are that prevent HIV positive adolescents from taking their anti-HIV medicines and if those barriers cluster together. The information collected will be used to develop and validate a schema for classifying HIV medication adherence by barriers to adherence or clusters of barriers to adherence. This classification schema could then be used in the development of interventions that better meet the needs of HIV-infected youth.

Study identification

NCT ID
NCT00106678
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
1,200 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
12 Years to 24 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2004 (Type not available)
Primary completion
Apr 2005 (Actual)
Completion
Apr 2005 (Actual)
Last update posted
Mar 1, 2017

2004 – 2005

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Children's Hospital of Los Angeles Los Angeles California 90027 —
University of California at San Diego San Diego California 92103 —
University of California at San Francisco San Francisco California 94143 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Children's Diagnostic and Treatment Center Fort Lauderdale Florida 33316 —
University of Miami Miami Florida 33101 —
University of South Florida Tampa Florida 33606 —
Stroger Hospital of Cook County Chicago Illinois 60612 —
Tulane University New Orleans Louisiana 70112 —
University of Maryland Medical School Baltimore Maryland 21204 —
Johns Hopkins Hospital Baltimore Maryland 21224 —
Childrens Hospital Boston Boston Massachusetts 02115 —
Weill Medical College of Cornell University-New York Presbyterian Hospital New York New York 10021 —
Mount Sinai Hospital New York New York 10128 —
Montefiore Medical Center The Bronx New York 10467 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00106678, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2017 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00106678 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →